GB0009622D0 - Spray dispenser for opioid antagonists - Google Patents

Spray dispenser for opioid antagonists

Info

Publication number
GB0009622D0
GB0009622D0 GBGB0009622.2A GB0009622A GB0009622D0 GB 0009622 D0 GB0009622 D0 GB 0009622D0 GB 0009622 A GB0009622 A GB 0009622A GB 0009622 D0 GB0009622 D0 GB 0009622D0
Authority
GB
United Kingdom
Prior art keywords
spray dispenser
opioid antagonists
opioid
antagonists
dispenser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0009622.2A
Other versions
GB2349818A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Britannia Pharmaceuticals Ltd
Original Assignee
Britannia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd
Publication of GB0009622D0 publication Critical patent/GB0009622D0/en
Publication of GB2349818A publication Critical patent/GB2349818A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/07—General characteristics of the apparatus having air pumping means
    • A61M2205/071—General characteristics of the apparatus having air pumping means hand operated

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Mechanical Engineering (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB0009622A 1999-04-19 2000-04-18 Spray dispenser for opioid antagonists Withdrawn GB2349818A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9908921.1A GB9908921D0 (en) 1999-04-19 1999-04-19 Spray dispenser for opiod antagonists

Publications (2)

Publication Number Publication Date
GB0009622D0 true GB0009622D0 (en) 2000-06-07
GB2349818A GB2349818A (en) 2000-11-15

Family

ID=10851820

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9908921.1A Ceased GB9908921D0 (en) 1999-04-19 1999-04-19 Spray dispenser for opiod antagonists
GB0009622A Withdrawn GB2349818A (en) 1999-04-19 2000-04-18 Spray dispenser for opioid antagonists

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB9908921.1A Ceased GB9908921D0 (en) 1999-04-19 1999-04-19 Spray dispenser for opiod antagonists

Country Status (5)

Country Link
EP (1) EP1171099A1 (en)
JP (1) JP2002541921A (en)
AU (1) AU4419300A (en)
GB (2) GB9908921D0 (en)
WO (1) WO2000062757A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2042161A1 (en) 1997-10-01 2009-04-01 Novadel Pharma Inc. Propellant-free spray composition comprising anti-emetic agent
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
WO2003077867A2 (en) * 2002-03-14 2003-09-25 Euro-Celtique, S.A. Naltrexone hydrochloride compositions
PT2316456T (en) 2003-04-29 2017-09-05 Orexigen Therapeutics Inc Compositions for affecting weight loss comprising an opioid antagonist and bupropion
CN1726915B (en) * 2004-07-27 2013-04-24 中国人民解放军军事医学科学院毒物药物研究所 Nasal cavity drug delivery system and combination of naloxone hydrochloride and preparation method
DK2135603T3 (en) 2005-11-22 2013-03-25 Orexigen Therapeutics Inc Compositions and Methods for Increasing Insulin Sensitivity
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
AU2007319472B2 (en) 2006-11-09 2013-01-17 Nalpropion Pharmaceuticals Llc Methods Of Administering Weight Loss Medications
US20110144145A1 (en) 2008-05-30 2011-06-16 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
AU2011203867B2 (en) 2010-01-11 2015-12-03 Nalpropion Pharmaceuticals Llc Methods of providing weight loss therapy in patients with major depression
IT1400067B1 (en) * 2010-05-21 2013-05-17 Molteni & C LIQUID NASAL SPRAY CONTAINING NALTREXONE WITH LOW DOSAGE.
MX354249B (en) * 2011-05-13 2018-02-20 Euro Celtique Sa Intranasal pharmaceutical dosage forms comprising naloxone.
EP2858640B1 (en) 2012-06-06 2020-03-25 Nalpropion Pharmaceuticals LLC Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk
US9192570B2 (en) 2013-12-20 2015-11-24 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
US10085937B2 (en) 2014-03-14 2018-10-02 Adapt Pharma Limited Nasal drug products and methods of their use
US9561177B2 (en) 2014-03-14 2017-02-07 Adapt Pharma Limited Nasal drug products and methods of their use
CN106163499A (en) * 2014-03-14 2016-11-23 欧皮安特制药有限公司 Nasal medicine product and using method thereof
US9480644B2 (en) 2014-03-14 2016-11-01 Opiant Pharmaceuticals, Inc. Nasal drug products and methods of their use
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US20160008277A1 (en) * 2014-07-09 2016-01-14 Lightlake Therapeutics Inc. Co-packaged drug products
US20180092839A1 (en) * 2016-10-03 2018-04-05 Lance L. Gooberman Medicated spray for treatment of substance abuse, overdose, addiction and impulse control disorders
CA3041308A1 (en) * 2016-10-21 2018-04-26 Somniferum Labs LLC Method, system and apparatus for controlled delivery of opioid and other medications
AU2020245535B2 (en) * 2019-03-26 2022-06-30 Pocket Naloxone Corp. Devices and methods for delivering pharmaceutical compositions
EP3946547A4 (en) 2019-03-26 2023-01-18 Pocket Naloxone Corp. Devices and methods for delivering pharmaceutical compositions
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
US10653690B1 (en) 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
US11484672B2 (en) * 2019-10-01 2022-11-01 Shareef J. Biltagi Opioid overdose treatment assembly
SI3962455T1 (en) 2020-05-18 2022-11-30 Orexo Ab New pharmaceutical composition for drug delivery
US11278709B1 (en) 2021-03-12 2022-03-22 Pocket Naloxone Corp. Drug delivery device and methods for using same
EP4236921A1 (en) 2021-11-25 2023-09-06 Orexo AB Pharmaceutical composition comprising adrenaline

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464378A (en) * 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
WO1987002586A2 (en) * 1985-10-29 1987-05-07 Key Pharmaceuticals, Inc. Method and composition for blocking antigen-induced allergic responses
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US4880813A (en) * 1988-07-22 1989-11-14 Baker Cummins Pharmaceuticals, Inc. Method of treatment for allergic rhinitis
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
CA2201358C (en) * 1994-09-30 2004-06-08 Jurgen Regenold Pharmaceutical composition
DE59804534D1 (en) * 1997-02-05 2002-07-25 Jago Res Ag Muttenz MEDICAL AEROSOL FORMULATIONS
ES2189269T3 (en) * 1997-12-03 2003-07-01 Britannia Pharmaceuticals Ltd IMPROVEMENTS IN MEDICATIONS FOR THE TREATMENT OF ASTHMA.

Also Published As

Publication number Publication date
GB9908921D0 (en) 1999-06-16
GB2349818A (en) 2000-11-15
WO2000062757A1 (en) 2000-10-26
JP2002541921A (en) 2002-12-10
AU4419300A (en) 2000-11-02
EP1171099A1 (en) 2002-01-16

Similar Documents

Publication Publication Date Title
GB0009622D0 (en) Spray dispenser for opioid antagonists
AU9317101A (en) Aerosol spray dispenser
GB2354999B (en) Dispenser
IL134219A0 (en) Spray dispenser
GB9819981D0 (en) Spray dispenser
AU142234S (en) Aerosol dispenser
AU140442S (en) Dispenser
AU141721S (en) Dispenser head
AU140425S (en) Dispenser
AU4511901A (en) Nonpeptide kappa opioid receptor antagonists
AU140586S (en) Dispenser
GB9924844D0 (en) Dispenser
GB9906552D0 (en) Metering dispenser
IL129884A0 (en) Spray dispenser
AU141579S (en) Dispenser
AU140706S (en) Dispenser
TW420047U (en) Improved structure for spray nozzle
GB0024003D0 (en) Spray dispenser
AU139570S (en) Dispensing nozzle
IL150203A0 (en) Non peptide tachykinin receptor antagonists
CA87683S (en) Dispenser
AU141722S (en) Dispenser head
TW478408U (en) Structure improvement for spraying nozzle
IL148118A0 (en) Improved spray dispenser
GB9909403D0 (en) Dispenser

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)